Description:

In this talk, I will be discussing examples from our research of how epigenetic and molecular biomarkers can be used to augment traditional epidemiological analyses of health outcomes and various related exposures. In particular, this talk will focus on the importance of epigenetics and molecular epidemiology for developing new biomarkers of cancer risk, and how markers related to aging (telomere length and DNA methylation-based epigenetic age acceleration) are associated with disease risk and with health-related exposures such as the AHA’s Simple 7.